30 results match your criteria: "UCLA Ocular Inflammatory Disease Center[Affiliation]"
Ocul Immunol Inflamm
March 2000
UCLA Ocular Inflammatory Disease Center, Jules Stein Institute, Los Angeles, CA 90095-7003, USA.
Br J Ophthalmol
July 2000
UCLA Ocular Inflammatory Disease Center, the Jules Stein Eye Institute, and the Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, USA.
Aim: Individuals with human immunodeficiency virus (HIV) infection were evaluated for evidence of abnormal polymorphonuclear leucocyte (PMN) rigidity, which can alter capillary blood flow.
Methods: The transit time of individual PMN through 8 microm pores in a cell transit analyser was used as a measure of cell rigidity. PMN transit time was compared between HIV infected individuals (n=45) with and without CMV retinitis and HIV negative controls (n=17).
Ocul Immunol Inflamm
December 1999
Department of Ophthalmology, UCLA Ocular Inflammatory Disease Center, UCLA School of Medicine, Jules Stein Eye Institute, Los Angeles, CA 90095-7003, USA.
Potent antiretroviral therapy can result in substantial improvement in the immune function of patients with AIDS. In some patients with preexisting cytomegalovirus (CMV) retinitis, a consequence of this improved immune function is increased intraocular inflammation. This phenomenon, termed 'immune recovery uveitis', is characterized by anterior segment and vitreous inflammatory reactions.
View Article and Find Full Text PDFOcul Immunol Inflamm
December 1999
Jules Stein Eye Institute, Department of Ophthalmology, UCLA Ocular Inflammatory Disease Center, UCLA School of Medicine, Los Angeles, CA 90095-7003, USA.
The management of AIDS-related cytomegalovirus (CMV) retinitis is evolving because of newly available anti-CMV drugs and because of the effect of potent antiretroviral therapy. New management issues are related to the improved immune function that occurs with antiretroviral drug use and to associated increases in patient survival. Patients can be categorized on the basis of their history of exposure to antiretroviral drugs and to their immune status; these factors will influence choices between treatment options.
View Article and Find Full Text PDFAm J Ophthalmol
July 1999
UCLA Ocular Inflammatory Disease Center, the Jules Stein Eye Institute, Los Angeles, California 90095-7003, USA.
Purpose: To describe two men with birdshot retinochoroidopathy whose severe subjective visual symptoms were controlled by long-term use of low-dose oral corticosteroid therapy.
Method: Chart review.
Results: Vision improved subjectively in both men after initial treatment with oral prednisone (1 mg/kg/day) and remained stable while taking 5 mg daily or less of prednisone for periods of 54 and 81 months.
Ophthalmology
January 1999
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute, USA.
Objective: A pilot study was performed to determine whether relationships exist between changes in a quantitative solution hybridization assay for cytomegalovirus (CMV) DNA in the blood and development of CMV retinitis, development of nonocular CMV disease, or reactivation of pre-existing CMV retinitis lesions.
Design: Observational case series.
Participants: Two groups of human immunodeficiency virus-infected patients: 10 CMV antibody-positive patients with CD4+ T-lymphocyte counts of less than 50 ml and no CMV disease at baseline and 11 patients with CMV retinitis but no extraocular CMV disease at baseline.
A pANCA autoantibody (antineutrophil cytoplasmic antibody, perinuclear pattern) has been described in uveitis patients, but its correlation with systemic illnesses and the specific type of pANCA has not been defined. The goals of this study were to determine the (1) frequency of pANCA autoantibodies in uveitis, (2) systemic associations in the pANCA + uveitis patients, and (3) type of pANCA antigen recognized by the uveitis-associated autoantibody. Serum was obtained from 59 patients with anterior uveitis or panuveitis and from nonuveitis controls.
View Article and Find Full Text PDFAm J Ophthalmol
March 1998
UCLA Ocular Inflammatory Disease Center, the Jules Stein Eye Institute, and Department of Ophthalmology, University of California, Los Angeles, School of Medicine, 90095-7003, USA.
Purpose: To describe the clinical features of a disorder characterized by chronic multifocal retinal infiltrates and uveitis in individuals with human immunodeficiency virus (HIV) disease.
Methods: We reviewed the medical records of HIV-infected patients with multifocal retinal infiltrates of unknown cause seen by investigators at four institutions. The following data were collected: demographic characteristics, presenting signs and symptoms, laboratory test results, and course of disease.
Ophthalmology
May 1997
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute, UCLA 90095-7003, USA.
Background: Pseudomonal scleritis is a serious and potentially blinding infection that usually is resistant to medical management.
Methods: Results for three patients with pseudomonal scleritis who were treated with both topical anti-infectives and a combination of intravenous ceftazidime and aminoglycoside are presented in this case series.
Results: All three patients had a rapid response to the addition of combination intravenous drug therapy to topical therapy; eradication of the infection and healing of the ocular surface occurred within 8 weeks.
Am J Ophthalmol
February 1997
Purpose: To report a case of streptococcal infection of the upper respiratory tract in which bilateral anterior uveitis was the only complication.
Method: Serologic documentation of post-streptococcal immune disease. The duration of inflammation was consistent with other forms of poststreptococcal immune disease.
Purpose: To report rapidly progressive rhino-orbitocerebral mucormycosis in a 47-year-old woman with both diabetes mellitus and the acquired immunodeficiency syndrome (AIDS).
Method: Case report including postmortem examination of the eyes, orbit, and brain of a patient with rhino-orbitocerebral mucormycosis, diabetes mellitus, and AIDS.
Results: Invasion by hyphae of the Rhizopus species produced an occlusive vasculitis and massive infarction of the optic chiasm.
Retina
February 1997
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute 90095-7003, USA.
Purpose: The authors discuss a possible relationship between systematic corticosteroid use and reactivation of ocular toxoplasmosis.
Methods: Patients were identified who developed foci of recurrent toxoplasmic retinochoroiditis while being treated with systemic corticosteroids. Case histories were reviewed retrospectively.
Am J Ophthalmol
January 1996
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute, UCLA School of Medicine 90095-7003, USA.
Purpose: Most uveitis case series have come from tertiary care centers, and the relative frequencies of disorders they report may reflect referral bias. We sought information about the types of uveitis encountered in the general practice of ophthalmology.
Methods: We prospectively examined 213 consecutive cases of general uveitis, defined as intraocular inflammation other than cytomegalovirus retinopathy, seen by a group of community-based comprehensive ophthalmologists.
Br J Ophthalmol
December 1995
UCLA Ocular Inflammatory Disease Center, Department of Ophthalmology, UCLA School of Medicine, USA.
Am J Ophthalmol
September 1995
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute, 90095-7003, USA.
Purpose: We sought to understand better the efficacy and risks of local therapies (direct placement of drug into the eye) for the treatment of cytomegalovirus retinopathy. This understanding can be used to design rational treatment regimens, to formulate indications for use of local therapy, and to establish criteria for assessment of future results in this area.
Methods: We collected information about local therapies through a review of published literature.
Ophthalmology
July 1995
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute, Los Angeles, CA 90095-7003, USA.
Background: Vogt-Koyanagi-Harada (VKH) syndrome is associated with human leukocyte antigen (HLA)-B54, -DR4, -DR beta 1*0405, -DQ4, and -DR53 in Japanese patients. Disease-associated HLA specificities may differ among races. This study examined HLA associations with VKH syndrome in Hispanic patients living in southern California, a racial subgroup at increased risk for the disease.
View Article and Find Full Text PDFAm J Ophthalmol
July 1995
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute 90024-7003, USA.
Purpose: Periocular injection of corticosteroids is a common treatment for vision loss in patients with intermediate uveitis. However, this treatment has the potential for serious side effects. We sought to determine the effects of such injections in a series of patients.
View Article and Find Full Text PDFAm J Ophthalmol
May 1995
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute 90024-7003, USA.
Purpose: A previous dose-ranging study of foscarnet maintenance therapy for cytomegalovirus retinopathy showed a positive relationship between dose and survival but could not confirm a relationship between dose and time to first progression. This retrospective analysis of data from that study was undertaken to determine whether there was a relationship between dose and progression rates, which reflects the amount of retina destroyed when progression occurs.
Methods: Patients were randomly given one of two foscarnet maintenance therapy doses (90 mg/kg of body weight/day [FOS-90 group] or 120 mg/kg of body weight/day [FOS-120 group] after induction therapy.
Invest Ophthalmol Vis Sci
April 1995
UCLA Ocular Inflammatory Disease Center, University of California at Los Angeles School of Medicine 90024-7003, USA.
Purpose: To evaluate the pharmacokinetics of topically applied clarithromycin, a new macrolide antibiotic, at various concentrations in a rabbit model.
Methods: Clarithromycin in dosages of 10, 20, and 40 mg/ml was administered topically every 2 hours for 48 hours to three groups of 16 New Zealand albino rabbits. Both corneas were treated.
Background: The progressive outer retinal necrosis syndrome is a recently recognized variant of necrotizing herpetic retinopathy. This report characterizes more fully its clinical features and course.
Methods: Using standardized clinical criteria, patients with progressive outer retinal necrosis syndrome from four institutions were identified.
Am J Ophthalmol
May 1994
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute, Department of Ophthalmology, UCLA School of Medicine 90024-7003.
Ophthalmology
March 1994
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute.
Background: Cytomegalovirus (CMV) and Toxoplasma gondii both cause necrotizing retinopathy in immunosuppressed hosts. Because of the high prevalence of serum antibodies to these agents in the general population and the risks associated with retinal biopsies, diagnosis of these infections is usually based on clinical findings alone, but the two infections can be confused with one another because of similar clinical features. Accurate diagnosis is critical, however, because both diseases are treatable but require different medical therapies.
View Article and Find Full Text PDFThe efficacy of three topical antibiotic treatments for Mycobacterium fortuitum (strain ATCC-6841) keratitis were compared in rabbits. Rabbits were treated with ciprofloxacin (3 mg/ml) or clarithromycin (20 mg/ml) or a combination of amikacin (100 mg/ml) and vancomycin (50 mg/ml). All three treatments significantly reduced the number of organisms in treated eyes compared to untreated, control eyes (all P values < .
View Article and Find Full Text PDFIn recent years tuberculosis has reemerged as a serious public health problem, raising the possibility that tuberculous eye disease may also become more prevalent. The predominant route by which tubercle bacilli reach the eye is through the bloodstream, after infecting the lungs. The pulmonary loci might not be evident clinically or radiographically.
View Article and Find Full Text PDFArch Ophthalmol
October 1992
UCLA Ocular Inflammatory Disease Center, Jules Stein Eye Institute 90024-7003.
Cytomegalovirus retinopathy lesions in patients with the acquired immunodeficiency syndrome may continue to enlarge despite ganciclovir sodium treatment. In an historical cohort study, we used serial, masked retinal photographs to calculate progression rates for 14 ganciclovir-treated patients known to have disease progression and for 17 untreated patients. The median period of evaluation was 23.
View Article and Find Full Text PDF